Literature DB >> 22453178

Comparative peptidome analyses of the profiles of the peptides ranging from 1-10 KD in CSF samples pooled from probable sporadic CJD and non-CJD patients.

Cao Chen1, Di Xiao, Wei Zhou, Yong-Chan Zhang, Qi Shi, Chan Tian, Jin Zhang, Chun-Xi Zhou, Jian-Zhong Zhang, Xiao-Ping Dong.   

Abstract

The shotgun strategy applying tandem mass spectrometry has been widely used to identify the proteins that are differentially distributed among diseases for its high reliability and efficiency. To find out the potential difference of protein profiles in cerebrospinal fluids (CSF) between Creutzfeldt-Jakob disease (CJD) and non-CJD patients, especially in the fraction ranging from 1-10 KD, the CSF samples of 40 probable sporadic CJD (sCJD) patients, 32 non-CJD cases with dementia and 17 non-CJD cases without dementia were separately pooled and enriched by the magnetic beads based weak cation exchange chromatography (MB-WCX). After trypsin digestion, each enriched CSF was separated and identified by RP-HPLC-ESI-QTOF MS/MS. In total, 42, 53 and 47 signals of proteins were identified in the pooled CSF fraction less than 10 KD of probable sCJD, non-CJD with dementia and non-CJD without dementia, respectively. Compared with that of probable sCJD, the similarity of CSF protein profiles of non-CJD with dementia (76.2%) were higher than that of non-CJD without dementia (57.1%). Nine CSF proteins were found to be specially observed in probable sCJD group. Those data may help to select the potential biomarkers for diagnosis of CJD. Additionally, further studies of the small segments of cellular proteins in CSF of CJD patients may also provide scientific clues for understanding the neuropathogenesis of TSEs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22453178      PMCID: PMC3338965          DOI: 10.4161/pri.6.1.18082

Source DB:  PubMed          Journal:  Prion        ISSN: 1933-6896            Impact factor:   3.931


  14 in total

1.  Clinical proteomics of the cerebrospinal fluid: Towards the discovery of new biomarkers.

Authors:  Stéphane Roche; Audrey Gabelle; Sylvain Lehmann
Journal:  Proteomics Clin Appl       Date:  2008-03       Impact factor: 3.494

2.  Standardized peptidome profiling of human urine by magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Authors:  Georg Martin Fiedler; Sven Baumann; Alexander Leichtle; Anke Oltmann; Julia Kase; Joachim Thiery; Uta Ceglarek
Journal:  Clin Chem       Date:  2007-02-01       Impact factor: 8.327

Review 3.  Proteolipid protein gene: Pelizaeus-Merzbacher disease in humans and neurodegeneration in mice.

Authors:  K Woodward; S Malcolm
Journal:  Trends Genet       Date:  1999-04       Impact factor: 11.639

4.  Analysis of the urinary peptidome associated with Helicobacter pylori infection.

Authors:  Di Xiao; Fan-Liang Meng; Li-Hua He; Yi-Xin Gu; Jian-Zhong Zhang
Journal:  World J Gastroenterol       Date:  2011-02-07       Impact factor: 5.742

5.  Current clinical diagnosis in Creutzfeldt-Jakob disease: identification of uncommon variants.

Authors:  I Zerr; W J Schulz-Schaeffer; A Giese; M Bodemer; A Schröter; K Henkel; H J Tschampa; O Windl; A Pfahlberg; B J Steinhoff; O Gefeller; H A Kretzschmar; S Poser
Journal:  Ann Neurol       Date:  2000-09       Impact factor: 10.422

Review 6.  Diagnosis of Creutzfeldt-Jakob disease and related human spongiform encephalopathies.

Authors:  T Weber; M Otto; M Bodemer; I Zerr
Journal:  Biomed Pharmacother       Date:  1997       Impact factor: 6.529

7.  Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases).

Authors:  H Budka; A Aguzzi; P Brown; J M Brucher; O Bugiani; F Gullotta; M Haltia; J J Hauw; J W Ironside; K Jellinger
Journal:  Brain Pathol       Date:  1995-10       Impact factor: 6.508

8.  Cystatin C as a potential cerebrospinal fluid marker for the diagnosis of Creutzfeldt-Jakob disease.

Authors:  Jean-Charles Sanchez; Elisabeth Guillaume; Pierre Lescuyer; Laure Allard; Odile Carrette; Alex Scherl; Jennifer Burgess; Garry L Corthals; Pierre R Burkhard; Denis F Hochstrasser
Journal:  Proteomics       Date:  2004-08       Impact factor: 3.984

9.  Serum biomarkers to differentiate benign and malignant mammographic lesions.

Authors:  Susanna Shin; Lisa Cazares; Heather Schneider; Shamina Mitchell; Christine Laronga; O John Semmes; Roger R Perry; Richard R Drake
Journal:  J Am Coll Surg       Date:  2007-05       Impact factor: 6.113

10.  Urinary alpha1-antichymotrypsin: a biomarker of prion infection.

Authors:  Gino Miele; Harald Seeger; Denis Marino; Ralf Eberhard; Mathias Heikenwalder; Katharina Stoeck; Max Basagni; Richard Knight; Alison Green; Francesca Chianini; Rudolf P Wüthrich; Christoph Hock; Inga Zerr; Adriano Aguzzi
Journal:  PLoS One       Date:  2008-12-05       Impact factor: 3.240

View more
  2 in total

1.  Global protein differential expression profiling of cerebrospinal fluid samples pooled from Chinese sporadic CJD and non-CJD patients.

Authors:  Cao Chen; Di Xiao; Wei Zhou; Qi Shi; Hui-Fang Zhang; Jin Zhang; Chan Tian; Jian-Zhong Zhang; Xiao-Ping Dong
Journal:  Mol Neurobiol       Date:  2013-08-04       Impact factor: 5.590

Review 2.  Biomarkers for sporadic Creutzfeldt-Jakob disease.

Authors:  Sanam Soomro; Chandra Mohan
Journal:  Ann Clin Transl Neurol       Date:  2016-04-25       Impact factor: 4.511

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.